Skip to main content
SpringerLink
Log in

IBS Patient’s Guide

  • Chapter
  • First Online:
Introduction to Gastrointestinal Diseases Vol. 1

  • 957 Accesses

Abstract

In this chapter, we will discuss the role of intestinal microbiota, lifestyle and eating habits in IBS patients. Before pharmacological treatment patients should consider changing lifestyle and diet, as they may be potential triggers for IBS symptoms. We will indicate which daily products are proper and which should be avoided by IBS patients because of exacerbation of disease symptoms. We will shortly describe how to lead healthy life and what the impact of physical activity on IBS symptoms is. We will explain that control, but not treatment, is the key management concept in IBS patients. Finally, we will define psychological aspects of IBS development and how important is to maintain psychological homeostasis. The continuous control of the doctor and regular good contact between the doctor and the patient play an important role in the disease remission.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Abbreviations

FODMAP:

Fermentable oligosaccharides, disaccharides, monosaccharides, and polyol

GI:

Gastrointestinal

IBS:

Irritable bowel syndrome

IBS-C:

Constipation-predominant-irritable bowel syndrome

IBS-D:

Diarrhea predominant-irritable bowel syndrome

SIBO:

Small intestinal bacterial overgrowth

References

  1. Biedermann L, Rogler G (2015) The intestinal microbiota: its role in health and disease. Eur J Pediatr 174(2):151–167

    CAS  PubMed  Google Scholar 

  2. Ohman L, Simren M (2013) Intestinal microbiota and its role in irritable bowel syndrome (IBS). Curr Gastroenterol Rep 15(5):323

    PubMed  Google Scholar 

  3. Porter CK, Choi D, Cash B, Pimentel M, Murray J, May L et al (2013) Pathogen-specific risk of chronic gastrointestinal disorders following bacterial causes of foodborne illness. BMC Gastroenterol 13:46

    PubMed  PubMed Central  Google Scholar 

  4. Halvorson HA, Schlett CD, Riddle MS (2006) Postinfectious irritable bowel syndrome–a meta-analysis. Am J Gastroenterol 101(8):1894–1899

    PubMed  Google Scholar 

  5. Lee BJ, Bak YT (2011) Irritable bowel syndrome, gut microbiota and probiotics. J Neurogastroenterol Motil 17(3):252–266

    PubMed  PubMed Central  Google Scholar 

  6. Ghoshal UC, Kumar S, Mehrotra M, Lakshmi C, Misra A (2010) Frequency of small intestinal bacterial overgrowth in patients with irritable bowel syndrome and chronic non-specific diarrhea. J Neurogastroenterol Motil 16(1):40–46

    PubMed  PubMed Central  Google Scholar 

  7. Chung CS, Chang PF, Liao CH, Lee TH, Chen Y, Lee YC et al (2016) Differences of microbiota in small bowel and faeces between irritable bowel syndrome patients and healthy subjects. Scand J Gastroenterol 51(4):410–419

    CAS  PubMed  Google Scholar 

  8. Dlugosz A, Winckler B, Lundin E, Zakikhany K, Sandstrom G, Ye W et al (2015) No difference in small bowel microbiota between patients with irritable bowel syndrome and healthy controls. Sci Rep 5:8508

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Posserud I, Stotzer PO, Bjornsson ES, Abrahamsson H, Simren M (2007) Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 56(6):802–808

    PubMed  Google Scholar 

  10. Patcharatrakul T, Gonlachanvit S (2016) Chili peppers, curcumins, and prebiotics in gastrointestinal health and disease. Curr Gastroenterol Rep 18(4):19

    PubMed  Google Scholar 

  11. Kerckhoffs AP, Ben-Amor K, Samsom M, van der Rest ME, de VJ, Knol J et al. (2011) Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome. J Med Microbiol 60(Pt 2):236–245

    Google Scholar 

  12. Si JM, Yu YC, Fan YJ, Chen SJ (2004) Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol 10(12):1802–1805

    PubMed  PubMed Central  Google Scholar 

  13. Salonen A, de Vos WM, Palva A (2010) Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology 156(Pt 11):3205–3215

    CAS  PubMed  Google Scholar 

  14. Cuomo R, Andreozzi P, Zito FP, Passananti V, De CG, Sarnelli G (2014) Irritable bowel syndrome and food interaction. World J Gastroenterol 20(27):8837–8845

    PubMed  PubMed Central  Google Scholar 

  15. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA et al (2011) Linking long-term dietary patterns with gut microbial enterotypes. Science 334(6052):105–108

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Simren M, Barbara G, Flint HJ, Spiegel BM, Spiller RC, Vanner S et al (2013) Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 62(1):159–176

    PubMed  Google Scholar 

  17. Bonfrate L, Tack J, Grattagliano I, Cuomo R, Portincasa P (2013) Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. Scand J Gastroenterol 48(9):995–1009

    PubMed  Google Scholar 

  18. Sisson G, Ayis S, Sherwood RA, Bjarnason I (2014) Randomised clinical trial: A liquid multi-strain probiotic versus placebo in the irritable bowel syndrome–a 12 week double-blind study. Aliment Pharmacol Ther 40(1):51–62

    CAS  PubMed  Google Scholar 

  19. Gareau MG, Sherman PM, Walker WA (2010) Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol 7(9):503–514

    PubMed  PubMed Central  Google Scholar 

  20. Didari T, Mozaffari S, Nikfar S, Abdollahi M (2015) Effectiveness of probiotics in irritable bowel syndrome: updated systematic review with meta-analysis. World J Gastroenterol 21(10):3072–3084

    PubMed  PubMed Central  Google Scholar 

  21. Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR (2009) Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 29(5):508–518

    CAS  PubMed  Google Scholar 

  22. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I et al (2010) Prebiotic effects: metabolic and health benefits. Br J Nutr 104(Suppl 2):S1–S63

    CAS  PubMed  Google Scholar 

  23. Mazzawi T, Hausken T, Gundersen D, El-Salhy M (2013) Effects of dietary guidance on the symptoms, quality of life and habitual dietary intake of patients with irritable bowel syndrome. Mol Med Rep 8(3):845–852

    CAS  PubMed  Google Scholar 

  24. Ford AC, Quigley EM, Lacy BE, Lembo AJ, Saito YA, Schiller LR et al (2014) Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol 109(10):1547–1561

    PubMed  Google Scholar 

  25. Bogovic MB, Obermajer T, Lipoglavsek L, Sernel T, Locatelli I, Kos M et al (2016) Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial. J Dairy Sci 99(7):5008–5021

    Google Scholar 

  26. Borody TJ, Khoruts A (2012) Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol 9(2):88–96

    CAS  Google Scholar 

  27. Iacovou M, Tan V, Muir JG, Gibson PR (2015) The low FODMAP diet and its application in East and Southeast Asia. J Neurogastroenterol Motil 21(4):459–470

    PubMed  PubMed Central  Google Scholar 

  28. Miwa H (2012) Life style in persons with functional gastrointestinal disorders–large-scale internet survey of lifestyle in Japan. Neurogastroenterol Motil 24(5):464–471 (e217)

    Google Scholar 

  29. Okami Y, Kato T, Nin G, Harada K, Aoi W, Wada S et al (2011) Lifestyle and psychological factors related to irritable bowel syndrome in nursing and medical school students. J Gastroenterol 46(12):1403–1410

    PubMed  Google Scholar 

  30. Simren M, Mansson A, Langkilde AM, Svedlund J, Abrahamsson H, Bengtsson U et al (2001) Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion 63(2):108–115

    CAS  PubMed  Google Scholar 

  31. Bohn L, Storsrud S, Tornblom H, Bengtsson U, Simren M (2013) Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol 108(5):634–641

    PubMed  Google Scholar 

  32. Nanda R, James R, Smith H, Dudley CR, Jewell DP (1989) Food intolerance and the irritable bowel syndrome. Gut 30(8):1099–1104

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Mazzawi T, Hausken T, Gundersen D, El-Salhy M (2013) Effects of dietary guidance on the symptoms, quality of life and habitual dietary intake of patients with irritable bowel syndrome. Mol Med Rep 8(3):845–852

    CAS  PubMed  Google Scholar 

  34. Gonlachanvit S (2010) Are rice and spicy diet good for functional gastrointestinal disorders? J Neurogastroenterol Motil 16(2):131–138

    PubMed  PubMed Central  Google Scholar 

  35. Omagari K, Murayama T, Tanaka Y, Yoshikawa C, Inoue S, Ichimura M et al (2013) Mental, physical, dietary, and nutritional effects on irritable bowel syndrome in young Japanese women. Intern Med 52(12):1295–1301

    PubMed  Google Scholar 

  36. Bohn L, Storsrud S, Tornblom H, Bengtsson U, Simren M (2013) Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol 108(5):634–641

    PubMed  Google Scholar 

  37. El-Salhy M, Gundersen D (2015) Diet in irritable bowel syndrome. Nutr J 14:36

    PubMed  PubMed Central  Google Scholar 

  38. Staudacher HM, Whelan K, Irving PM, Lomer MC (2011) Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet 24(5):487–495

    CAS  PubMed  Google Scholar 

  39. Gonlachanvit S, Coleski R, Owyang C, Hasler W (2004) Inhibitory actions of a high fibre diet on intestinal gas transit in healthy volunteers. Gut 53(11):1577–1582

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Eswaran S, Muir J, Chey WD (2013) Fiber and functional gastrointestinal disorders. Am J Gastroenterol 108(5):718–727

    CAS  PubMed  Google Scholar 

  41. Shepherd SJ, Parker FC, Muir JG, Gibson PR (2008) Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol 6(7):765–771

    CAS  PubMed  Google Scholar 

  42. Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG (2014) A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 146(1):67–75

    CAS  PubMed  Google Scholar 

  43. Gibson PR, Shepherd SJ (2005) Personal view: food for thought–western lifestyle and susceptibility to Crohn’s disease. The FODMAP hypothesis. Aliment Pharmacol Ther 21(12):1399–1409

    CAS  PubMed  Google Scholar 

  44. Marsh A, Eslick EM, Eslick GD (2016) Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr 55(3):897–906

    CAS  PubMed  Google Scholar 

  45. Staudacher HM, Lomer MC, Anderson JL, Barrett JS, Muir JG, Irving PM et al (2012) Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr 142(8):1510–1518

    CAS  PubMed  Google Scholar 

  46. Ong DK, Mitchell SB, Barrett JS, Shepherd SJ, Irving PM, Biesiekierski JR et al (2010) Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol 25(8):1366–1373

    CAS  PubMed  Google Scholar 

  47. Williams EA, Nai X, Corfe BM (2011) Dietary intakes in people with irritable bowel syndrome. BMC Gastroenterol 11:9

    PubMed  PubMed Central  Google Scholar 

  48. Biesiekierski JR, Muir JG, Gibson PR (2013) Is gluten a cause of gastrointestinal symptoms in people without celiac disease? Curr Allergy Asthma Rep 13(6):631–638

    CAS  PubMed  Google Scholar 

  49. Biesiekierski JR, Newnham ED, Irving PM, Barrett JS, Haines M, Doecke JD et al (2011) Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol 106(3):508–514

    CAS  PubMed  Google Scholar 

  50. Wald A, Rakel D (2008) Behavioral and complementary approaches for the treatment of irritable bowel syndrome. Nutr Clin Pract 23(3):284–292

    PubMed  Google Scholar 

  51. Berg LK, Fagerli E, Martinussen M, Myhre AO, Florholmen J, Goll R (2013) Effect of fructose-reduced diet in patients with irritable bowel syndrome, and its correlation to a standard fructose breath test. Scand J Gastroenterol 48(8):936–943

    CAS  PubMed  Google Scholar 

  52. Kubo M, Fujiwara Y, Shiba M, Kohata Y, Yamagami H, Tanigawa T et al (2011) Differences between risk factors among irritable bowel syndrome subtypes in Japanese adults. Neurogastroenterol Motil 23(3):249–254

    CAS  PubMed  Google Scholar 

  53. Simren M, Mansson A, Langkilde AM, Svedlund J, Abrahamsson H, Bengtsson U et al (2001) Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion 63(2):108–115

    CAS  PubMed  Google Scholar 

  54. Ostgaard H, Hausken T, Gundersen D, El-Salhy M (2012) Diet and effects of diet management on quality of life and symptoms in patients with irritable bowel syndrome. Mol Med Rep 5(6):1382–1390

    PubMed  Google Scholar 

  55. Bertram S, Kurland M, Lydick E, Locke GR III, Yawn BP (2001) The patient’s perspective of irritable bowel syndrome. J Fam Pract 50(6):521–525

    CAS  PubMed  Google Scholar 

  56. Guo YB, Zhuang KM, Kuang L, Zhan Q, Wang XF, Liu SD (2015) Association between diet and lifestyle habits and irritable bowel syndrome: a case-control study. Gut Liver 9(5):649–656

    PubMed  Google Scholar 

  57. Lustyk MK, Jarrett ME, Bennett JC, Heitkemper MM (2001) Does a physically active lifestyle improve symptoms in women with irritable bowel syndrome? Gastroenterol Nurs 24(3):129–137

    CAS  PubMed  Google Scholar 

  58. Sullivan SN, Wong C, Heidenheim P (1994) Does running cause gastrointestinal symptoms? A survey of 93 randomly selected runners compared with controls. N Z Med J 107(984):328–331

    CAS  PubMed  Google Scholar 

  59. Levy RL, Cain KC, Jarrett M, Heitkemper MM (1997) The relationship between daily life stress and gastrointestinal symptoms in women with irritable bowel syndrome. J Behav Med 20(2):177–193

    CAS  PubMed  Google Scholar 

  60. Fujii Y, Nomura S (2008) A prospective study of the psychobehavioral factors responsible for a change from non-patient irritable bowel syndrome to IBS patient status. Biopsychosoc Med 2:16

    PubMed  PubMed Central  Google Scholar 

  61. Padhy SK, Sahoo S, Mahajan S, Sinha SK (2015) Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”? J Neurosci Rural Pract 6(4):568–577

    PubMed  PubMed Central  Google Scholar 

  62. Surdea-Blaga T, Baban A, Dumitrascu DL (2012) Psychosocial determinants of irritable bowel syndrome. World J Gastroenterol 18(7):616–626

    PubMed  PubMed Central  Google Scholar 

  63. Stanculete MF, Pojoga C, Dumitrascu DL (2014) Experience of anger in patients with irritable bowel syndrome in Romania. Clujul Med 87(2):98–101

    PubMed  PubMed Central  Google Scholar 

  64. Tosic-Golubovic S, Miljkovic S, Nagorni A, Lazarevic D, Nikolic G (2010) Irritable bowel syndrome, anxiety, depression and personality characteristics. Psychiatr Danub 22(3):418–424

    PubMed  Google Scholar 

  65. Koloski NA, Jones M, Kalantar J, Weltman M, Zaguirre J, Talley NJ (2012) The brain–gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut 61(9):1284–1290

    CAS  PubMed  Google Scholar 

  66. Donker GA, Foets M, Spreeuwenberg P (1999) Patients with irritable bowel syndrome: health status and use of health care services. Br J Gen Pract 49(447):787–792

    CAS  PubMed  PubMed Central  Google Scholar 

  67. Song SW, Park SJ, Kim SH, Kang SG (2012) Relationship between irritable bowel syndrome, worry and stress in adolescent girls. J Korean Med Sci 27(11):1398–1404

    PubMed  PubMed Central  Google Scholar 

  68. Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM (1992) Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut 33(6):825–830

    CAS  PubMed  PubMed Central  Google Scholar 

  69. Fukudo S, Suzuki J (1987) Colonic motility, autonomic function, and gastrointestinal hormones under psychological stress on irritable bowel syndrome. Tohoku J Exp Med 151(4):373–385

    CAS  PubMed  Google Scholar 

  70. Chang FY (2014) Irritable bowel syndrome: the evolution of multi-dimensional looking and multidisciplinary treatments. World J Gastroenterol 20(10):2499–2514

    CAS  PubMed  PubMed Central  Google Scholar 

  71. Clouse RE, Lustman PJ (2005) Use of psychopharmacological agents for functional gastrointestinal disorders. Gut 54(9):1332–1341

    CAS  PubMed  PubMed Central  Google Scholar 

  72. Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P et al (2007) Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 56(12):1770–1798

    CAS  PubMed  PubMed Central  Google Scholar 

  73. Ford AC, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P (2009) Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 58(3):367–378

    CAS  PubMed  Google Scholar 

  74. Flik CE, van Rood YR, Laan W, Smout AJ, Weusten BL, Whorwell PJ et al (2011) A randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study). BMC Gastroenterol 11:137

    PubMed  PubMed Central  Google Scholar 

  75. O’Sullivan MA, Mahmud N, Kelleher DP, Lovett E, O’Morain CA (2000) Patient knowledge and educational needs in irritable bowel syndrome. Eur J Gastroenterol Hepatol 12(1):39–43

    PubMed  Google Scholar 

  76. Halpert A, Dalton CB, Palsson O, Morris C, Hu Y, Bangdiwala S et al (2008) Patient educational media preferences for information about irritable bowel syndrome (IBS). Dig Dis Sci 53(12):3184–3190

    PubMed  Google Scholar 

  77. Ringstrom G, Storsrud S, Posserud I, Lundqvist S, Westman B, Simren M (2010) Structured patient education is superior to written information in the management of patients with irritable bowel syndrome: a randomized controlled study. Eur J Gastroenterol Hepatol 22(4):420–428

    PubMed  Google Scholar 

  78. Di Palma JA, Herrera JL (2012) The role of effective clinician-patient communication in the management of irritable bowel syndrome and chronic constipation. J Clin Gastroenterol 46(9):748–751

    PubMed  Google Scholar 

  79. Halpert A (2011) Irritable bowel syndrome: what do patients really want? Curr Gastroenterol Rep 13(4):331–335

    PubMed  Google Scholar 

  80. Kelley JM, Lembo AJ, Ablon JS, Villanueva JJ, Conboy LA, Levy R et al (2009) Patient and practitioner influences on the placebo effect in irritable bowel syndrome. Psychosom Med 71(7):789–797

    PubMed  PubMed Central  Google Scholar 

  81. Vanuytsel T, Tack JF, Boeckxstaens GE (2014) Treatment of abdominal pain in irritable bowel syndrome. J Gastroenterol 49(8):1193–1205

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Supported by grant from the Medical University of Lodz (#and 502-03/1-156-04/502-14-297) and grants from National Science Centre (#UMO-2013/11/N/NZ7/00724 and UMO-2014/12/T/NZ7/00252). MZ is the recipient of the Polish L’Oréal UNESCO Awards for Women in Science and Polpharma Foundation Scholarship.

Author information

Authors and Affiliations

  1. Faculty of Medicine, Department of Biochemistry, Medical University of Lodz, Mazowiecka 6/8, 92-215, Lodz, Poland

    Marta Zielińska

Authors
  1. Marta Zielińska
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marta Zielińska .

Editor information

Editors and Affiliations

  1. Department of Biochemistry, Medical University of Lodz, Lodz, Poland

    Jakub Fichna

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Zielińska, M. (2017). IBS Patient’s Guide. In: Fichna, J. (eds) Introduction to Gastrointestinal Diseases Vol. 1. Springer, Cham. https://doi.org/10.1007/978-3-319-49016-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-49016-8_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-49015-1

  • Online ISBN: 978-3-319-49016-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation